Motiva Breast Implants Breast Implant Illness: 2026 Guide
Navigating the world of breast augmentation can feel overwhelming, especially with complex topics like Breast Implant Illness (BII) in the conversation. A primary question for many is whether newer technologies, like Motiva implants, reduce the risk of BII. While no implant can be guaranteed to be risk-free, understanding the design differences is key. This guide breaks down what you need to know about breast implant safety, the concerns around BII, and how Motiva’s specific features aim to enhance patient safety and peace of mind.
What Exactly Is Breast Implant Illness (BII)?
Breast Implant Illness, or BII, is a term used to describe a wide range of systemic symptoms that some women report after getting breast implants. The U.S. Food and Drug Administration (FDA) notes these can include chronic fatigue, brain fog, joint and muscle pain, anxiety, hair loss, and unexplained weight changes. These symptoms have been reported with all kinds of implants, whether saline or silicone, smooth or textured. For some, issues start soon after surgery, while for others, they may not appear for years.
While BII is not an official medical diagnosis and lacks a specific diagnostic test, the concerns are real for many. Between 2008 and 2024, the FDA received over 10,000 reports from women describing these types of symptoms. The most common complaints were fatigue and joint pain. Many women report that their symptoms significantly improve after having their implants removed (explantation) or pursuing revision breast augmentation.
The Evidence and Controversy Around BII
The medical community is still working to understand BII. There isn’t a definitive scientific link that proves implants cause a unique illness, but the volume of patient reports has spurred serious investigation.
Here’s what the research suggests:
A Notable Association: A 2025 systematic review found that key symptoms like fatigue and joint pain were reported three times more often in women with breast implants compared to those without.
Silicone and Ruptures: The same analysis pointed to a higher risk of BII type symptoms in patients with silicone gel implants and a slightly higher likelihood in those with ruptured implants.
Immune System Activation: One theory involves “gel bleed”, where tiny silicone particles can escape an intact implant shell over time. Some immunology experts believe this exposure can lead to chronic immune system activation, triggering BII symptoms in people who are susceptible.
Because the vast majority of people with implants do not experience these issues, researchers believe genetics or other individual factors likely play a role. The ongoing debate highlights the importance of open dialogue and informed consent between you and your surgeon.
At her Denver practice, Dr. Leela Mundra believes in empowering patients through education. If you’re exploring your options and have concerns about motiva breast implants breast implant illness, a thorough consultation can help you weigh the knowns and unknowns. You can request a personalized consultation here.
BII vs. BIA-ALCL: Understanding the Difference
It is crucial to distinguish BII from another health concern: Breast Implant–Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
BII is a collection of systemic symptoms without a specific diagnostic test.
BIA-ALCL is a rare, diagnosable cancer of the immune system.
BIA-ALCL is not breast cancer. It’s a type of non-Hodgkin’s lymphoma that typically forms in the fluid and scar tissue surrounding an implant. The World Health Organization officially recognized it as a disease related to breast implants in 2016.
Textured vs. Smooth Implants: A Major Safety Shift
The conversation around BIA-ALCL led to a major shift in implant selection, focusing on the implant’s outer surface.
The Textured Implant Risk
Research has established an overwhelming link between BIA-ALCL and textured implants, which have a rough, sandpaper like surface. These implants were designed to grip tissue and reduce movement, but their surface provides more area for bacteria to hide, potentially leading to chronic inflammation.
The risk, while rare, is significant. As of 2019, 573 unique cases of BIA-ALCL and 33 deaths were identified worldwide, prompting a global recall of Allergan’s BIOCELL textured implants, which were linked to over 80% of cases. To date, nearly all confirmed BIA-ALCL patients had exposure to a textured implant at some point. As a result, many surgeons have stopped using highly textured implants.
The Smooth Implant Advantage
Smooth implants have a slick outer shell and are not associated with BIA-ALCL. The choice between textured and smooth now heavily favors smooth surfaces for enhanced safety. This is where advanced implants like Motiva come in.
How Biofilm Connects to Implant Complications
A key piece of the safety puzzle is biofilm. This is a thin, slimy layer of bacteria that can form on any implanted medical device, including breast implants.
Even in a sterile operating room, a few bacteria can adhere to the implant. On a textured surface, these bacteria have more nooks and crannies to hide in, forming a protected community. This biofilm can trigger chronic, low grade inflammation, which is a known cause of complications like capsular contracture (hardening of the scar tissue) and is the leading theory behind what triggers BIA-ALCL.
This is why implant surface technology is so important. A surface that resists bacterial attachment can potentially reduce the risk of long term inflammatory problems.
Motiva’s SmoothSilk® Surface: A New Approach to Safety
Motiva implants are considered a next generation option, engineered specifically to improve biocompatibility. Their most notable feature is the SmoothSilk® surface, a unique nano textured shell.
Though it feels completely smooth to the touch, under a microscope it has a very fine, organized pattern. This design was created to be more harmonious with the body’s tissues.
Studies have shown that the SmoothSilk® surface:
Reduces Bacterial Adhesion: It demonstrates significantly lower bacterial attachment compared to both traditional textured and other smooth implants.
Causes Less Inflammation: The surface has been shown to provoke the least amount of inflammation in surrounding tissues.
By minimizing biofilm and inflammation, the SmoothSilk® surface aims to reduce the root causes of common implant complications. This is a primary reason why, in a meta analysis of 4,784 patients, Motiva implants were associated with an extremely low capsular contracture rate of just 0.5% and zero reported cases of BIA-ALCL.
Do Motiva Implants Lower the Risk of BII?
This is the big question for many patients. Could choosing Motiva implants reduce the likelihood of developing motiva breast implants breast implant illness?
Theoretically, there are good reasons to be optimistic. The potential link between BII and chronic inflammation is a leading theory. By creating a cleaner, less inflammatory environment around the implant, Motiva’s design directly addresses this concern. The implants also feature a special barrier layer and BluSeal® coating to minimize silicone “gel bleed,” another suspected trigger for immune reactions in some individuals.
However, it is critical to have realistic expectations. No implant can be guaranteed to be free from the risk of BII. The condition is complex and likely involves an individual’s unique immune system and genetic predispositions. While choosing an implant designed for superior biocompatibility like Motiva is a logical step to reduce known risk factors, it does not eliminate the risk entirely. The FDA is clear that systemic symptoms have been reported with all types of implants.
Patient Counseling: An Open Conversation About Your Health
Today, discussing breast implant illness is a standard and essential part of the consultation process. The era of dismissing patient concerns is over. The FDA now requires that all patients receive a detailed checklist outlining the risks of both BII and BIA-ALCL before surgery.
In a boutique practice like Dr. Leela Mundra’s, the focus is on a concierge, education first approach. During your one on one consultation in Denver (see what to expect at a consultation; or for future patients in Tampa and St. Petersburg, FL), you can expect:
A Validating Discussion: Your concerns about BII will be heard and taken seriously.
Honest Information: You’ll learn what science knows and what it doesn’t, so you can make a truly informed decision.
A Tailored Plan: Dr. Mundra will review all your options, from the latest generation implants like Motiva to alternatives like fat transfer or a breast lift, to find the right path for your goals and comfort level.
Your health and confidence are paramount. A great surgeon acts as your partner, providing the information you need and supporting the decision that is best for you. You can also read our patient reviews to hear real experiences.
Considering breast augmentation and want to learn more about your options, including how the risk of motiva breast implants breast implant illness is addressed? Schedule a private consultation with Dr. Leela Mundra today.
Frequently Asked Questions
Prefer to watch explanations? Explore our patient education videos.
1. What are the most common symptoms of Breast Implant Illness?
The most frequently reported symptoms include fatigue, brain fog (memory and concentration issues), joint pain, muscle aches, anxiety, and hair loss.
2. Can Motiva implants still cause Breast Implant Illness?
Yes, it’s possible. While Motiva implants are designed with advanced safety features that may reduce factors linked to inflammation, no implant is risk free. The FDA has stated that BII symptoms have been associated with all types of breast implants.
3. Are smooth implants safer than textured implants?
When it comes to the risk of BIA-ALCL, a rare immune system cancer, smooth implants are considered significantly safer. BIA-ALCL is overwhelmingly linked to textured implant surfaces. For this reason, many surgeons now exclusively use smooth or nano smooth surface implants like Motiva.
4. What is the SmoothSilk® surface on Motiva implants?
SmoothSilk® is Motiva’s proprietary nano textured surface. It feels smooth but has a microscopic texture designed to be highly biocompatible. Studies show it reduces bacterial attachment and inflammation, which is linked to lower rates of complications like capsular contracture.
5. Does removing implants cure BII?
Many women who experience BII symptoms report a significant improvement or complete resolution of their symptoms after their implants are removed (explantation). However, this is not guaranteed for everyone, as the exact cause of BII is still being researched.
6. How do I know if my symptoms are related to my breast implants?
If you have breast implants and are experiencing unexplained systemic symptoms like chronic fatigue or joint pain, it’s important to speak with your plastic surgeon and primary care doctor. They can help rule out other medical conditions and discuss whether your symptoms could be related to your implants.
7. Why choose a surgeon who offers Motiva implants?
Surgeons who offer the latest technologies like Motiva implants are often dedicated to providing patients with the most advanced options focused on safety and natural results. Choosing a plastic surgeon who is knowledgeable about motiva breast implants breast implant illness ensures you will have an informed and supportive partner in your healthcare journey.